Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.530
-0.100 (-2.16%)
At close: Feb 21, 2025, 4:00 PM
4.480
-0.050 (-1.10%)
After-hours: Feb 21, 2025, 4:24 PM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $274.23 million as of February 21, 2025. Its market cap has increased by 572.12% in one year.
Market Cap
274.23M
Enterprise Value
170.84M
1-Year Change
572.12%
Ranking
Category
Stock Price
$4.53
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $274.23M, an increase of 64.21%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 274.20M | -3.42% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |